Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where David L. Gardner is active.

Publication


Featured researches published by David L. Gardner.


Biological Psychiatry | 1990

CSF metabolites in borderline personality disorder compared with normal controls

David L. Gardner; Peter B. Lucas; Rex W. Cowdry

Cerebrospinal metabolites were measured in 17 patients with borderline personality disorder and 17 normal controls. There were no significant differences between the two groups in levels of 5-hydroxyindoleacetic acid (5-HIAA), homovanillic acid (HVA), or 3-methoxy-4-hydroxyphenylglycol (MHPG). Within the borderline group, lower levels of CSF 5-HIAA were significantly associated with a history of genuine suicide attempts, but were not associated with violence, self-mutilation, or with the presence of major depression. Thus, CSF 5-HIAA levels are not distinctively low in a diagnostic group characterized by impulsivity and suicidal behavior, but within that group may be associated with genuine suicide attempts.


Journal of Nervous and Mental Disease | 1991

Self-ratings of anger and hostility in borderline personality disorder.

David L. Gardner; E. Leibenluft; K. M. O'leary; Rex W. Cowdry

Forty-six patients with borderline personality disorder with and without major depression and 27 normal volunteers completed the Buss-Durkee Hostility Inventory, a self-rating scale of anger and hostility. The patients with borderline personality had significantly higher scores than the normal volunteers. The scores of the patients with borderline personality disorders were not related to gender, treatment or research setting, the degree of acute distress, or the presence of major depression. These findings suggest that a proneness to anger and hostility are enduring characteristics of borderline personality disorder and that anger and depression may represent independent clinical conditions with independent biological mechanisms regulating these two affective states.


Biological Psychiatry | 1987

Intravenous procaine as a probe of limbic system activity in psychiatric patients and normal controls.

Charles H. Kellner; Robert M. Post; Frank W. Putnam; Rex W. Cowdry; David L. Gardner; Mitchel A. Kling; Marcia Minichiello; Joan R. Trettau; Richard Coppola

Evidence from animal and human studies suggests that procaine hydrochloride may selectively activate limbic system structures and suppress neocortical structures. We administered a series of intravenous bolus doses of procaine hydrochloride to 31 subjects (7 with affective disorders, 17 with borderline personality disorder, and 7 healthy normal volunteers). Dose-related cognitive and sensory distortions and illusions were observed; affective experiences ranged widely from euphoric to dysphoric. Topographic electroencephalogram (EEG) analysis indicated selective increases in fast activity (26-45 Hz) over the temporal lobes; the degree of increase in this activity correlated with degree of dysphoria experienced. Procaine was associated with increases in secretion of cortisol, adrenocorticotrophic hormone (ACTH), and prolactin, but not with growth hormone. These preliminary data are consistent with the possibility that procaine might serve as a clinically useful probe of psychosensory, affective, electrophysiological, and endocrine effects referable to the limbic system.


Journal of Nervous and Mental Disease | 1987

Soft sign neurological abnormalities in borderline personality disorder and normal control subjects.

David L. Gardner; Peter B. Lucas; Rex W. Cowdry

Patients with borderline personality disorder were found to have a significantly greater number of soft sign neurological abnormalities when compared with a group of normal control subjects. Sensitivity analysis revealed that the presence of two or more soft signs differentiated the two groups statistically. The authors speculate that nonfocal soft sign neurological abnormalities may reflect underlying central nervous system dysfunction, which may in turn be associated with the development of borderline personality disorders.


Psychiatry Research-neuroimaging | 1989

Cerebral structure in borderline personality disorder

Peter B. Lucas; David L. Gardner; Rex W. Cowdry; David Pickar

Computed tomographic (CT) scans of brains of patients with borderline personality disorder and normal volunteers were analyzed for ventricle-brain ratios, third ventricular size, and evidence of frontal lobe atrophy. There were no significant differences between the two groups on any of these measures except for a narrower third ventricle in borderline patients, which could be accounted for by the narrower third ventricle observed in female subjects overall. While borderline patients may show signs of subtle neurological dysfunction, they do not show evidence of structural brain pathology.


Progress in Neuro-psychopharmacology & Biological Psychiatry | 1987

Neuroendocrine effects of limbic activation by electrical, spontaneous, and pharmacological modes: Relevance to the pathophysiology of affective dysregulation in psychiatric disorders

Mitchel A. Kling; Charles H. Kellner; Robert M. Post; Rex W. Cowdry; David L. Gardner; Richard Coppola; Frank W. Putnam; Philip W. Gold

1. Literature is reviewed that implicates various limbic structures (particularly amygdala and hippocampus) in the modulation of stress-associated neuroendocrine systems. 2. Procaine and related local anesthetics may show a selective proclivity for activating limbic structures. 3. Procaine stimulates ACTH-cortisol and prolactin, but not growth hormone secretion. This pattern is most comparable to that elicited by stimuli which act bilaterally on temporal lobe and limbic areas. 4. Procaine may be a useful agent for helping to elucidate the anatomic and physiologic basis for mood, endocrine, and cognitive dysregulation associated with stress and affective disorders. 5. The endocrine concomitants of limbic activation may have relevance to the course and symptom complex of affective disorders and related psychiatric conditions.


American psychiatric association conference | 1991

Homogeneous group therapy of borderline personality disorder

Kathleen M. O'Leary; Edward R. Turner; David L. Gardner; Rex W. Cowdry

The authors maintained a time-limited, diagnostically homogeneous psychotherapy group of borderline patients for one year. The group progressed through prototypical stages of group development, but each phase was marked by variations of the aggressive drive and defenses against aggression that are characteristic of this disorder. The group provided a well-suited forum for the exploration of suicidal and homicidal impulses and the development of an observing ego. Despite the limits on generalizability from this group, it appears that group psychotherapy can be a valuable adjunctive modality for some borderline patients.


Archives of General Psychiatry | 1988

Pharmacotherapy of Borderline Personality Disorder: Alprazolam, Carbamazepine, Trifluoperazine, and Tranylcypromine

Rex W. Cowdry; David L. Gardner


Journal of Personality Disorders | 1987

Special Feature the Inner Experience of the Borderline Self-Mutilator

Ellen Leibenluft; David L. Gardner; Rex W. Cowdry


American Journal of Psychiatry | 1991

Neuropsychological Testing of Patients With Borderline Personality Disorder

Kathleen M. O'Leary; P. Brouwers; David L. Gardner; Rex W. Cowdry

Collaboration


Dive into the David L. Gardner's collaboration.

Top Co-Authors

Avatar

Rex W. Cowdry

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Kathleen M. O'Leary

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Peter B. Lucas

University of California

View shared research outputs
Top Co-Authors

Avatar

Charles H. Kellner

Icahn School of Medicine at Mount Sinai

View shared research outputs
Top Co-Authors

Avatar

Frank W. Putnam

Indiana University Bloomington

View shared research outputs
Top Co-Authors

Avatar

Mitchel A. Kling

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar

Richard Coppola

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Robert M. Post

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Alexis A. Giese

University of Colorado Denver

View shared research outputs
Top Co-Authors

Avatar

David Pickar

National Institutes of Health

View shared research outputs
Researchain Logo
Decentralizing Knowledge